Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors
Titel:
Monitoring circulating epithelial tumor cells (CETCs) during primary systemic chemotherapy including trastuzumab for early prediction of outcome in patients with Her2/neu-positive tumors
Auteur:
Gajda, M. Camara, O. Oppel, S. Kroll, T. Jörke, C. Krauspe, S. Hammer, U. Rabenstein, C. Untch, M. Runnebaum, I.B. Pachmann, K.